Skip to content

Evaluation of Non-Ablative Laser for Treatment of Direct Brow Lift Scars

Evaluation of Non-Ablative Laser for Treatment of Direct Brow Lift Scars

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02032641
Enrollment
9
Registered
2014-01-10
Start date
2013-06-30
Completion date
2015-05-31
Last updated
2017-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Scar

Keywords

Non-ablative laser, Scar revision, direct brow lift

Brief summary

The purpose of this study is to determine the efficacy of the 1064nm Neodymium yttrium aluminum garnet (Nd:YAG) laser (Laser Genesis, Cutera TM) in the treatment of surgical scar after direct brow lift.

Detailed description

Patients who undergo a direct brow lift may participate in this study. Participants will receive laser treatment on one of the two surgical wounds (side of treatment will be chosen randomly by an independent source). Treatment parameters will be 500 spots and 10-14 megajoules (mJ) depending on skin type. The opposite side brow scar will not be treated until 1 month after the study is completed (if the patient elects to treat the contralateral brow after study completion this will be done at no charge to the patient). This treatment will be given at 2-4 week intervals for 6 treatments. Photographs will be taken at each visit, and they will be assessed based on different parameters by an examiner, as well as judged by the patient based on overall appearance.

Interventions

DEVICELaser treatment

Non-ablative, non-fractional, microsecond-pulsed Nd:YAG laser 500-1000 pulses, 0.3 msec pulse duration, 10-14 J/cm2, 5 mm spot size

Sponsors

University of Miami
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Undergoing or have undergone direct brow lift

Exclusion criteria

* under 18 years old * history of photodermatoses * receiving systemic isotretinoin within the preceding 6 months * undergoing other scar treatment in the brow area * pregnant patients * history of adverse outcomes related to non-ablative laser

Design outcomes

Primary

MeasureTime frameDescription
Relative Improvement1 month after final treatmentWhich scar, overall, appears to have improved more from initial to final visit, as rated by blinded examiner of photographs

Secondary

MeasureTime frameDescription
Overall Appearance10 minutes before first treatment and at the final visitSubjects were asked to rate overall cosmesis of both the treated and control scars on a 1-10 scale, with 1 being extremely poor and 10 being extremely excellent, as rated by participant
Hair Losswithin 1 hour after final treatmentAfter each laser session, subjects were asked to rate perceived amount of hair loss from both the treated and control scars on a 1-10 scale, with 1 being none at all and 10 being extremely significant

Countries

United States

Participant flow

Recruitment details

All patients who had undergone direct brow lift within the last three years were contacted by telephone, and an approved script was used for recruitment.

Pre-assignment details

Exclusion criteria included unilateral procedures, age less than 18 years, pregnancy, history of photodermatoses or adverse outcomes associated with laser, history of isotretinoin use within the prior six months, and active use of other scar treatment in the brow area.

Participants by arm

ArmCount
Laser Treatment and Control Group
Each patient was randomized to have one of two scars treated with Laser Genesis and a scar not treated with Laser Genesis, which was used as a control. Patients were not allowed to undergo laser or any other scar treatments with the exception of sun protection for the control scar for the duration of the study. The laser treatment was administered by manually scanning the rapidly pulsed laser in an even, painting motion throughout the entire treatment zone. The eyebrow hairs were covered with white tape to prevent inadvertent alopecia. The laser handpiece was oriented perpendicular to the skin at all times, at a distance of 1-2 cm. Patients were instructed throughout to give verbal feedback regarding if the area was too hot as an additional safeguard against epidermal damage. Laser treatment: Non-ablative, non-fractional, microsecond-pulsed Neodymium:Yttrium/Aluminum/Garnet laser 500-1000 pulses, 0.3 msec pulse duration, 10-14 J/cm2, 5 mm spot size
9
Total9

Baseline characteristics

CharacteristicLaser Treatment and Control Group
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
5 Participants
Age, Categorical
Between 18 and 65 years
4 Participants
Sex: Female, Male
Female
1 Participants
Sex: Female, Male
Male
8 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 50 / 4
serious
Total, serious adverse events
0 / 50 / 4

Outcome results

Primary

Relative Improvement

Which scar, overall, appears to have improved more from initial to final visit, as rated by blinded examiner of photographs

Time frame: 1 month after final treatment

Population: 3 graders masked to treatments were asked to judge side-by-side photographs of first and final visits for which scar improved more. Each pair of before-and-after photos was graded twice by each examiner. Results are percentage of times treated scar was chosen by examiners as most improved (an analysis of 6 results per pair of photos).

ArmMeasureValue (MEAN)Dispersion
Laser Treatment SideRelative Improvement50.0 percentage of times treated scar chosenStandard Deviation 12.5
Control ScarRelative Improvement50.0 percentage of times treated scar chosenStandard Deviation 12.5
Secondary

Hair Loss

After each laser session, subjects were asked to rate perceived amount of hair loss from both the treated and control scars on a 1-10 scale, with 1 being none at all and 10 being extremely significant

Time frame: within 1 hour after final treatment

Population: Within 1 hour after treatment, subjects were given a mirror and asked to rate perceived hair loss for each side on a 1-10 scale, with 1 representing none and 10 representing very significant

ArmMeasureValue (MEAN)Dispersion
Laser Treatment SideHair Loss1 units on a scaleStandard Deviation 0
Control ScarHair Loss1 units on a scaleStandard Deviation 0
Secondary

Overall Appearance

Subjects were asked to rate overall cosmesis of both the treated and control scars on a 1-10 scale, with 1 being extremely poor and 10 being extremely excellent, as rated by participant

Time frame: 10 minutes before first treatment and at the final visit

Population: Patients were asked to grade overall cosmesis of both the treated and control scars on a 1-10 scale, with 1 being extremely poor and 10 being extremely excellent. Grading was done 10 minutes prior to each laser treatment and 4 weeks after final treatment

ArmMeasureGroupValue (MEAN)Dispersion
Laser Treatment SideOverall AppearanceBefore first treatment3.75 units on a scaleStandard Deviation 2.12
Laser Treatment SideOverall AppearanceFinal visit6.25 units on a scaleStandard Deviation 1.98
Control ScarOverall AppearanceBefore first treatment4.37 units on a scaleStandard Deviation 1.5
Control ScarOverall AppearanceFinal visit4.50 units on a scaleStandard Deviation 2.62
p-value: <0.05t-test, 1 sided
p-value: >0.1t-test, 1 sided

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026